UniProt ID | NOD1_HUMAN | |
---|---|---|
UniProt AC | Q9Y239 | |
Protein Name | Nucleotide-binding oligomerization domain-containing protein 1 | |
Gene Name | NOD1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 953 | |
Subcellular Localization | Cytoplasm. Cell membrane. Apical cell membrane. Basolateral cell membrane. Detected in the cytoplasm and at the cell membrane. Following bacterial infection, localizes to bacterial entry sites in the cell membrane. Recruited to the basolateral and ap | |
Protein Description | Enhances caspase-9-mediated apoptosis. Induces NF-kappa-B activity via RIPK2 and IKK-gamma. Confers responsiveness to intracellular bacterial lipopolysaccharides (LPS). Forms an intracellular sensing system along with ARHGEF2 for the detection of microbial effectors during cell invasion by pathogens. Required for RHOA and RIPK2 dependent NF-kappa-B signaling pathway activation upon S.flexneri cell invasion. Involved not only in sensing peptidoglycan (PGN)-derived muropeptides but also in the activation of NF-kappa-B by Shigella effector proteins IpgB2 and OspB. Recruits NLRP10 to the cell membrane following bacterial infection.. | |
Protein Sequence | MEEQGHSEMEIIPSESHPHIQLLKSNRELLVTHIRNTQCLVDNLLKNDYFSAEDAEIVCACPTQPDKVRKILDLVQSKGEEVSEFFLYLLQQLADAYVDLRPWLLEIGFSPSLLTQSKVVVNTDPVSRYTQQLRHHLGRDSKFVLCYAQKEELLLEEIYMDTIMELVGFSNESLGSLNSLACLLDHTTGILNEQGETIFILGDAGVGKSMLLQRLQSLWATGRLDAGVKFFFHFRCRMFSCFKESDRLCLQDLLFKHYCYPERDPEEVFAFLLRFPHVALFTFDGLDELHSDLDLSRVPDSSCPWEPAHPLVLLANLLSGKLLKGASKLLTARTGIEVPRQFLRKKVLLRGFSPSHLRAYARRMFPERALQDRLLSQLEANPNLCSLCSVPLFCWIIFRCFQHFRAAFEGSPQLPDCTMTLTDVFLLVTEVHLNRMQPSSLVQRNTRSPVETLHAGRDTLCSLGQVAHRGMEKSLFVFTQEEVQASGLQERDMQLGFLRALPELGPGGDQQSYEFFHLTLQAFFTAFFLVLDDRVGTQELLRFFQEWMPPAGAATTSCYPPFLPFQCLQGSGPAREDLFKNKDHFQFTNLFLCGLLSKAKQKLLRHLVPAAALRRKRKALWAHLFSSLRGYLKSLPRVQVESFNQVQAMPTFIWMLRCIYETQSQKVGQLAARGICANYLKLTYCNACSADCSALSFVLHHFPKRLALDLDNNNLNDYGVRELQPCFSRLTVLRLSVNQITDGGVKVLSEELTKYKIVTYLGLYNNQITDVGARYVTKILDECKGLTHLKLGKNKITSEGGKYLALAVKNSKSISEVGMWGNQVGDEGAKAFAEALRNHPSLTTLSLASNGISTEGGKSLARALQQNTSLEILWLTQNELNDEVAESLAEMLKVNQTLKHLWLIQNQITAKGTAQLADALQSNTGITEICLNGNLIKPEEAKVYEDEKRIICF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
129 | Phosphorylation | NTDPVSRYTQQLRHH CCCHHHHHHHHHHHH | 11.03 | 29978859 | |
130 | Phosphorylation | TDPVSRYTQQLRHHL CCHHHHHHHHHHHHC | 14.55 | 29978859 | |
141 | Phosphorylation | RHHLGRDSKFVLCYA HHHCCCCCCEEEEEE | 27.00 | 29978859 | |
217 | Phosphorylation | MLLQRLQSLWATGRL HHHHHHHHHHHHCCC | 30.39 | - | |
249 | S-palmitoylation | FKESDRLCLQDLLFK CHHHHHHHHHHHHHH | 3.14 | 29575903 | |
328 | Ubiquitination | KLLKGASKLLTARTG CHHHHHHHHHHHCCC | 47.16 | - | |
334 | Phosphorylation | SKLLTARTGIEVPRQ HHHHHHCCCCCCCHH | 39.79 | - | |
597 | Phosphorylation | LFLCGLLSKAKQKLL HHHHHHHHHHHHHHH | 35.29 | 24719451 | |
627 | Phosphorylation | LWAHLFSSLRGYLKS HHHHHHHHHHHHHHC | 18.10 | 24719451 | |
754 | Ubiquitination | VLSEELTKYKIVTYL ECCHHHHHCCEEEEE | 58.11 | - | |
784 | Ubiquitination | TKILDECKGLTHLKL HHHHHHCCCCCEEEC | 55.71 | - | |
797 | Phosphorylation | KLGKNKITSEGGKYL ECCCCEEECCCHHEE | 23.49 | 24719451 | |
798 | Phosphorylation | LGKNKITSEGGKYLA CCCCEEECCCHHEEE | 37.40 | 24719451 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NOD1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NOD1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NOD1_HUMAN | NOD1 | physical | 10329646 | |
CASP1_HUMAN | CASP1 | physical | 10329646 | |
CASP2_HUMAN | CASP2 | physical | 10329646 | |
CASP4_HUMAN | CASP4 | physical | 10329646 | |
CASP8_HUMAN | CASP8 | physical | 10329646 | |
CASP9_HUMAN | CASP9 | physical | 10329646 | |
RIPK2_HUMAN | RIPK2 | physical | 10329646 | |
CFLAR_HUMAN | CFLAR | physical | 10329646 | |
HS90A_HUMAN | HSP90AA1 | physical | 17435760 | |
SGT1_HUMAN | SUGT1 | physical | 17435760 | |
CSN6_HUMAN | COPS6 | physical | 17337451 | |
SGT1_HUMAN | SUGT1 | physical | 17420470 | |
HS90A_HUMAN | HSP90AA1 | physical | 17420470 | |
PSA7_HUMAN | PSMA7 | physical | 23839082 | |
SOX8_HUMAN | SOX8 | physical | 21988832 | |
RNF34_HUMAN | RNF34 | physical | 25012219 | |
A16L1_HUMAN | ATG16L1 | physical | 19898471 | |
NOD2_HUMAN | NOD2 | physical | 19898471 | |
RIPK2_HUMAN | RIPK2 | physical | 23300079 | |
A16L1_HUMAN | ATG16L1 | physical | 23300079 | |
UBC_HUMAN | UBC | physical | 23300079 | |
NOD1_HUMAN | NOD1 | physical | 23300079 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...